Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2001
11/01/2001WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001WO2001032866A3 Hybrid adaptor receptors
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036943 Mixture of analgesic and carrier
11/01/2001US20010036477 Oral administering
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407424A1 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001CA2407376A1 Peptide potentiation of acid-sensory ion channel in pain
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2407086A1 Integrin/adhesion antagonists
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2405680A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2405103A1 Chemical modification of mammalian urine and blood
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149105A1 4,5-pyrazinoxindoles as protein kinase inhibitors
10/31/2001EP1149099A2 Imidazo[4,5-c]-pyridine-4-on-derivatives
10/31/2001EP1149093A1 4-aryloxindoles as inhibitors of jnk protein kinases
10/31/2001EP1149092A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148876A1 Calcilytic compounds
10/31/2001EP1148875A1 Methods and compositions to enhance white blood cell count
10/31/2001EP1148873A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
10/31/2001EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
10/31/2001EP1044201A4 3-substituted adenines via2-thioxanthines
10/31/2001EP0980248B1 Improvements in or relating to long-acting antimicrobials
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists
10/31/2001EP0737192B1 Substituted morpholine derivatives and their use as therapeutic agents
10/31/2001DE10027258C1 Transdermal therapeutic system, for local/systemic delivery of non-steroidal antiinflammatory agents, comprises a permeable, elastic water and air permeable backing layer and an impermeable two-phase drug-containing matrix layer
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320039A Reduction of oxidative stress factors
10/30/2001US6310226 Vitamin D analogues
10/30/2001US6310217 Antiinflammatory and analgesic agents
10/30/2001US6310205 Intermediates for preparing 3-substituted adenines and 3,8-di-substituted 6-aminopurine derivatives for use as phosphodiesterase inhibitors.
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310099 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
10/30/2001US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/30/2001US6310042 Derivatives of carbohydrates and compositions containing them
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001US6309645 A method of suppressing an immune response in a mammal.
10/30/2001US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens.
10/30/2001US6309630 Non-steroidal anti-inflammatory ophthalmic suspensions
10/30/2001CA2084669C [3h,7h]thiazolo[3,4-a]pyridines with antiasthmatic and a antiinflammatory actions on the respiratory tract
10/30/2001CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
10/30/2001CA2047843C Method and product for the treatment of gastric disease
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079843A2 Screening method for compounds
10/25/2001WO2001079494A1 Agonist antibodies
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079479A2 Methods for selective targeting
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079206A1 Tricyclic quinazolinediones
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
1 ... 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 ... 1272